Hidehiro Fukuyama

Professor

Kansai Medical University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Hidehiro Fukuyama is a faculty member at Kansai Medical University in Japan. His research focuses on immunology, particularly in the context of COVID-19 and influenza virus interactions, antibody responses, and B-cell dynamics. Recent articles include studies on the neutralizing activity of SARS-CoV-2 post-vaccination and innovations in biosensing for COVID-19 vaccines. He is also involved in exploring the role of metabolic reprogramming in memory B cell formation and the effects of ultraviolet B exposure on regulatory T cells.

Articles (11)

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

yoichiro iwakura

Professor

University of Tokyo

JAPAN

View details

Jens K. Habermann

University of Lübeck

GERMANY

View details

Takeshi Inoue

Professor

University of Tokyo

JAPAN

View details

Makoto Tsuiji

Associate Professor

Hoshi University

JAPAN

View details

Satoshi Sawai

Professor

University of Tokyo

JAPAN

View details

Véronique Blanchard

GERMANY

View details

Riccardo Funari

Assistant professor

University of Bari Aldo Moro

ITALY

View details

Simon Eschweiler

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Mattias Collin

Lund University

SWEDEN

View details

Katsuyuki Yugi

Keio University

JAPAN

View details

Hiroaki Shime

Nagoya University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hidehiro Fukuyama

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan.

Nanoplasmonic multiplex biosensing for COVID-19 vaccines

Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.

Reply to Slominski et al.: UVB irradiation induces proenkephalin + regulatory T cells with a wound-healing function

Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells

Rap1 Is Essential for B-Cell Locomotion, Germinal Center Formation and Normal B-1a Cell Population

Exit from germinal center to become quiescent memory B cells depends on metabolic reprograming and provision of a survival signal.

IgG Fc sialylation is regulated during the germinal center reaction upon immunization with different adjuvants

Proenkephalin + regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function

Frontline Science: Conversion of neutrophils into atypical Ly6G+ SiglecF+ immune cells with neurosupportive potential in olfactory neuroepithelium.

Repurposing the Psoriasis Drug Oxarol to an ointment adjuvant for the influenza vaccine

Collaborators (11)

yoichiro iwakura

Jens K. Habermann

Takeshi Inoue

Makoto Tsuiji

Satoshi Sawai

Véronique Blanchard

Riccardo Funari

Simon Eschweiler

Mattias Collin

Katsuyuki Yugi

Hiroaki Shime

Make your next move.